Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22578793 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
Conditions: Glioblastoma Multiforme;   Primary Brain Tumor
Interventions: Drug: Temozolomide;   Drug: Bevacizumab
2 Completed Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
Conditions: Glioblastoma;   Anaplastic Astrocytoma
Interventions: Drug: Temozolomide;   Radiation: Radiotherapy of the partial brain.

Indicates status has not been verified in more than two years